Literature DB >> 16179735

Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney.

Charles E Wood1, Roderick Cousins, Daying Zhang, Maureen Keller-Wood.   

Abstract

Organic ions are excreted into the urine via the action of organic anion transporters (OATs). In adult kidney, both OAT1 and OAT3, both multispecific transporters, are abundant; OAT1 is a known transporter of para-aminohippurate (PAH) and OAT3 is a known transporter of sulfoconjugated estrogens. The present study was designed to test the hypotheses that the expression of both OAT1 and OAT3 are developmentally regulated and that the expression increases in late gestation. Fetal kidneys were collected at sacrifice of fetal sheep at 80, 100, 120, 130, and 145 days of gestation, as well as 1 day and 1 week after birth (n=4-5 per group). Renal tissue was separated into cortex and medulla and snap-frozen in liquid nitrogen for later extraction of mRNA. The expression levels of OAT1 and OAT3 were measured using real-time reverse transcriptase polymerase chain reaction (RT-PCR), with specific probes and primers designed in our laboratory. Cellular distribution of protein expression was identified using immunohistochemistry with commercially available antisera. The OAT1 and OAT3 mRNA in renal cortex was increased in the more mature animals. At 145 days of gestation, OAT1 mRNA abundance was increased and remained elevated postnatally. Compared with prenatal ages, OAT3 mRNA was increased postnatally. The expression of both transporters was not significantly changed as a function of development in the renal medulla. The protein expression of OAT1 and OAT3 was identified in tubular epithelium in renal cortex, although the immunoreactivity for OAT1 was greater than for OAT3. We conclude that there is a developmental pattern of expression of both OAT1 and OAT3 in ovine renal cortex, and that the pattern of expression suggests that the function of both transporters is likely to be greater starting in late gestation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179735     DOI: 10.1177/153537020523000909

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  8 in total

1.  Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: accelerating endocytosis of the transporter.

Authors:  Peng Duan; Shanshan Li; Guofeng You
Journal:  Eur J Pharmacol       Date:  2009-10-28       Impact factor: 4.432

2.  Dynamics of Organic Anion Transporter-Mediated Tubular Secretion during Postnatal Human Kidney Development and Maturation.

Authors:  Jeremiah D Momper; Jin Yang; Mary Gockenbach; Florin Vaida; Sanjay K Nigam
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-18       Impact factor: 8.237

Review 3.  Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.

Authors:  Susan M Abdel-Rahman; Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

4.  Expression of organic anion transporters 1 and 3 in the ovine fetal brain during the latter half of gestation.

Authors:  Roderick Cousins; Charles E Wood
Journal:  Neurosci Lett       Date:  2010-08-11       Impact factor: 3.046

5.  Cerebral hypoperfusion increases estrogen receptor abundance in the ovine fetal brain and pituitary.

Authors:  Charles E Wood
Journal:  Neuroendocrinology       Date:  2007-12-21       Impact factor: 4.914

Review 6.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 7.  Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.

Authors:  Jeremiah D Momper; Sanjay K Nigam
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-06-04       Impact factor: 4.481

8.  Blockade of estrogen action upregulates estrogen receptor-alpha mRNA in the fetal brain.

Authors:  Christine E Schaub; Charles E Wood
Journal:  Neonatology       Date:  2009-03-12       Impact factor: 4.035

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.